Quantcast

Latest Olaparib Stories

2015-04-20 23:02:55

More women with high-grade serous ovarian cancer could benefit from drug, according to Maurie Markman, M.D. Plainsboro, NJ (PRWEB) April 20, 2015 The

2015-04-20 12:33:18

PHILADELPHIA, April 20, 2015 /PRNewswire-USNewswire/ -- Stand Up To Cancer (SU2C), Ovarian Cancer Research Fund (OCRF), Ovarian Cancer National Alliance (OCNA), and National Ovarian Cancer Coalition

2015-04-08 08:26:31

LONDON, April 8, 2015 /PRNewswire/ -- SummaryGBI Research, has released the pharma report -"Ovarian Cancer Therapeutics in Major Developed Markets to 2020 - Late-Stage Pipeline

2015-02-10 23:00:44

Marketresearchreports.biz has announced the addition of the “Ovarian Cancer Therapeutics In Asia-Pacific Markets To 2020: Off Patent Chemo Regimens To Retain Dominance Despite New Launches”

2015-01-22 08:28:49

DALLAS, January 22, 2015 /PRNewswire/ -- RnRMarketResearch.com adds Ovarian Cancer Therapeutics in Asia-Pacific Markets to 2020 - Off-patent Chemo-regimens to Retain Dominance

2014-12-19 16:23:29

WILMINGTON, Del., Dec. 19, 2014 /PRNewswire/ -- AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved LYNPARZA(TM) (olaparib) capsules.

2014-11-24 23:08:39

RnRMarketResearch.com adds “Market Research Report on Global and Chinese Olaparib (CAS 763113-22-0) Industry, 2009-2019” Latest Report to its store. Dallas,

2014-10-08 12:25:30

Sales of Breast Cancer Therapies are Expected to Almost Double Through 2023, Fueled by Growth in Several Distinct Market Segments, According to Findings from Decision Resources Group BURLINGTON,

2014-07-02 08:24:16

LONDON, July 2, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:


Word of the Day
shotta
  • An armed gangster.
The word 'shotta' is an alteration of 'shooter'.